Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal JSFK (Jurnal Sains Farmasi & Klinis) Jurnal Kesehatan dr. Soebandi
Afifah Machlaurin
University of Jember
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Implementation of The Just-In-Time Method on Drug Inventory Efficiency at The Pharmacy Department of Kaliwates Hospital Jember Adityo Herjuno; Afifah Machlaurin; Yuni Retnaningtyas; Abu Khoiri; Wilda Zidni Ilma
Jurnal Kesehatan dr. Soebandi Vol 14 No 1 (2026): Jurnal Kesehatan dr. Soebandi
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Universitas dr. Soebandi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36858/jkds.v14i1.1060

Abstract

Background: During the Covid-19 pandemic, the management of drug inventory and sypply faces a great challenges. A common problem in the management of supplies at the pharmacy installation is the accumulation of drugs that are rarely used, which causes drugs to become damaged or expired, as well as the shortage of drugs that should be available. RSU Kaliwates Jember has implemented a strategy in 2023 to optimize the drug inventory in the Pharmacy department by applying a Just-In-Time strategy in drug purchasing. This study aims to analyze the impact of the strategy in three sector: drug procurement cost, total inventory cost, and inventory day. Methods:   The analysis applied the Quacy-experimental one group pretest-posttest design. The main goal is to analyze causal relationships by comparing the results of the two tests in order to determine the impact of the treatment. This study is a one-group pretest-posttest research design by comparing the value before and after the implementation of just-In-Time strategy, value at 2022 and 2023. The data was obtained from system management at RSU Kaliwates Jember (SIMRS) for procurement cost, inventory values, an inventory days. Results:   The analysis showed that there is a significant efficiency in drug procurement cost with a p-value of 0.041. For the total inventory value, the strategy could significantly reduce the value wiyh p-value of 0.006. In addition, the strategy could shorten significantly the inventory days with p-value 0.017. Conclusions:   This study conclude that the implementation of just-in-time strategy has an impact on improving the efficiency of drug inventory management especially in the reduction of the procurement cost, inventory value and inventory days. The impact of this strategy is worth to further analyze in the other sector such us in the drug wastage due to dead stock or expire drug and drug shortage that could affect the pharmacy care.
Comparative Economic and Clinical Utility of Adding Candesartan for Hypertension Management Najmiatul Fitria; Thang Nguyen; Afifah Machlaurin; Nabila Al Rizka; Dian Ayu Juwita
JSFK (Jurnal Sains Farmasi & Klinis) Vol 11 No 2 (2024): J Sains Farm Klin 11(2), August 2024
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.11.2.111-117.2024

Abstract

Introduction: Antihypertensive drugs require high costs because they are used over a long period. Therefore, consideration is needed in drug selection requirements, effectiveness, and price. This study aimed to see the beneficial results of hypertension therapy and the non-medical costs incurred by patients using cost-utility analysis (CUA). Method: This research was a prospective study. The incremental Cost-Utility Ratio (ICUR) of antihypertensive treatment was calculated using cost-utility data obtained through EQ-5D-5L questionnaires from outpatients at Universitas Andalas Hospital in January- March 2023 who met the inclusion and exclusion criteria. The costs used were from a patient perspective, consisting of direct medical and non-medical costs. This study compared standard treatment (amlodipine) with the addition of candesartan. Results: The number of respondents in this study was 67, consisting of 23 respondents (34.33%) using amlodipine alone and 44 respondents (65.67%) using the amlodipine-candesartan combination. The ICUR value obtained was IDR7,318,674/QALY. The difference in the average utility value of the amlodipine-candesartan combination with amlodipine alone is -0.02, and the difference in cost is -IDR12,224. Based on the cost-utility diagram, the amlodipine-candesartan combination group is included in the southwest quadrant (quadrant III), which illustrates that the cost required for the amlodipine-candesartan combination group is lower than the cost of the amlodipine single treatment group and the outcome is also not better (slightly lower or the same). Conclusion: It was recommended to prioritize using amlodipine alone for hypertension management, as it provides similar outcomes to the amlodipine-candesartan combination while incurring lower costs.
Co-Authors Abu Khoiri Adityo Herjuno Dian Ayu Juwita Nabila Al Rizka Najmiatul Fitria Thang Nguyen Wilda Zidni Ilma Yuni Retnaningtyas